Sep 29

QP 28 - Actionable Biomarkers: Guiding Therapy Selection and De-escalation

1165 - Assessing MMAI Algorithmic Fairness within Racial and Age Subgroups In NRG/RTOG Post-Radical Prostatectomy Phase III Trials

05:15pm - 05:20pm ET

Presenter(s)

Shalini Moningi, MD - Cleveland Clinic Taussig Cancer Institute, Cleveland, OH